For most people, Raynaud’s disease is uncomfortable but not dangerous. The primary form, which accounts for the majority of cases, causes temporary color changes and numbness in the fingers or toes when exposed to cold or stress, but it doesn’t damage tissue. The secondary form, linked to autoimmune diseases like scleroderma or lupus, is a different story and can lead to serious complications including open sores and, in rare cases, tissue loss.
Primary vs. Secondary: Two Very Different Conditions
The distinction between primary and secondary Raynaud’s is the single most important factor in how serious the condition is for you. Primary Raynaud’s has no known cause, typically starts between ages 15 and 30, and often first appears during the teenage years. It affects somewhere between 5% and 20% of women and 4% to 14% of men, making it surprisingly common. Attacks are unpleasant, with fingers turning white or blue and feeling numb or painful, but they resolve on their own within minutes once you warm up. Primary Raynaud’s almost never causes lasting harm.
Secondary Raynaud’s develops because of an underlying health condition, usually an autoimmune disease. It tends to appear later, around age 40, and the attacks are more severe, longer lasting, and more likely to cause real tissue damage. The most strongly associated conditions are scleroderma (a disease that hardens and scars the skin), lupus, rheumatoid arthritis, and Sjögren’s disease. Nearly all people with scleroderma experience Raynaud’s symptoms. If your Raynaud’s started later in life, affects one hand more than the other, or comes with other symptoms like joint pain, skin changes, or fatigue, that raises the likelihood of a secondary cause.
When Raynaud’s Becomes Dangerous
The serious complications of Raynaud’s are almost exclusively tied to the secondary form. When blood flow to the fingers is repeatedly and severely restricted, the tissue can break down, forming digital ulcers: small, painful open sores on the fingertips that heal slowly. In patients with scleroderma who already have digital ulcers, about 18% will experience gangrene at some point. That number comes from a large registry of nearly 4,700 scleroderma patients tracked over six years, and it underscores that this is not a rare complication in that specific population.
The progression follows a pattern. Raynaud’s attacks become more frequent and more severe. Blood vessels narrow permanently rather than just spasming temporarily. Ulcers form on the fingertips. If blood flow isn’t restored, the tissue dies. This escalation from vasospasm to permanent tissue damage is what doctors watch for, and it’s why secondary Raynaud’s requires ongoing monitoring.
For people with primary Raynaud’s, this kind of tissue damage is extremely uncommon. The blood vessels spasm but recover fully, and there’s no progressive narrowing over time.
How Doctors Tell the Difference
If you’re worried about which type you have, one of the most useful tools is a simple, painless exam called nailfold capillaroscopy. A doctor looks at the tiny blood vessels at the base of your fingernails under magnification. In primary Raynaud’s, these capillaries look normal. In secondary Raynaud’s, they show distinctive abnormalities: enlarged, irregular, or missing capillaries that signal an underlying autoimmune process. In one study, 48% of patients without a known autoimmune disease had completely normal capillary patterns, while those with secondary Raynaud’s consistently showed abnormal findings. Blood tests for autoimmune markers are usually ordered alongside this exam.
Only one finger or toe may be affected at first, with symptoms gradually spreading to other digits. The thumbs are less commonly involved than the other fingers.
What Triggers Attacks
Cold exposure is the most obvious trigger, but it doesn’t have to be extreme. Reaching into a freezer, holding a cold drink, or walking through an air-conditioned store can be enough. Emotional stress also triggers vasospasm in many people. For secondary Raynaud’s, additional triggers include vibrating tools (common in occupational settings), certain medications that constrict blood vessels, and smoking.
Avoiding known triggers is the first line of defense. Keeping your core body temperature warm matters as much as protecting your hands directly. Layering clothing, using hand warmers, and wearing insulated gloves before going outside rather than after your fingers are already cold can significantly reduce attack frequency.
Treatment for Mild to Moderate Cases
When lifestyle changes aren’t enough, calcium channel blockers are the most commonly used medication. These drugs relax and open small blood vessels, reducing both the frequency and severity of attacks. A review of 23 clinical trials found that treatment cut the average number of weekly attacks roughly in half, from about 14 per week down to 6. Higher doses tend to work better, and the benefit is more pronounced in primary Raynaud’s than in secondary cases where the blood vessel damage is more structural.
For many people with primary Raynaud’s, this combination of trigger avoidance and medication is enough to manage the condition comfortably for life.
Treatment for Severe Cases
When standard medications fail and tissue damage is progressing, more aggressive options exist. Botulinum toxin injections into the hand have shown promise for patients who don’t respond to conventional treatment. In a study following 15 patients over three years, five of seven patients with existing ulcers had complete healing within three months. The injections appear to work by relaxing the muscles around blood vessels and reducing the chemical signals that drive both vasoconstriction and pain. About 64% of patients rated their overall satisfaction above 8 out of 10 at the end of treatment.
For the most severe cases, where patients develop persistent ulcers, blue-black discoloration, or dry gangrene despite medical therapy, surgery becomes an option. A procedure called periarterial sympathectomy strips away the nerve fibers that signal blood vessels to constrict. In one study of patients with severe digital ischemia, half achieved complete ulcer healing within one month, and all ulcers were fully healed by six months. Pain scores dropped significantly as well. This surgery is reserved for people who have exhausted other options, but the outcomes are encouraging.
What Determines Your Outlook
If you have primary Raynaud’s, your long-term outlook is excellent. The condition may be annoying, especially in cold climates, but it poses no meaningful threat to your health. Some people find their symptoms improve over time.
If you have secondary Raynaud’s, the seriousness depends largely on the underlying disease. Scleroderma carries the highest risk of complications, while Raynaud’s associated with lupus or rheumatoid arthritis tends to be less likely to cause severe tissue damage. Regular monitoring, early treatment of ulcers, and management of the underlying condition are what keep secondary Raynaud’s from progressing.
The bottom line: Raynaud’s itself is rarely life-threatening. But it can be a warning sign of a more serious autoimmune condition, and in those cases, the vascular damage it causes deserves close attention. If your symptoms started after age 30, are getting worse over time, or involve sores that won’t heal, those are the signals that your Raynaud’s may need more than just a warm pair of gloves.